First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial (Q34590091)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial |
scientific article |
Statements
1 reference
First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial (English)
1 reference
Pieter Sonneveld
1 reference
Andrzej Hellmann
1 reference
Jan Walewski
1 reference
Tadeusz Robak
1 reference
Marek Wojtukiewicz
1 reference
Anton Hagenbeek
1 reference
Ole Gadeberg
1 reference
Peter Johnson
1 reference
Lars Møller Pedersen
1 reference
Brian K Link
1 reference
Michael Kneba
1 reference
Andreas Engert
1 reference
Mimi Flensburg
1 reference
Jørgen Petersen
1 reference
Nedjad Losic
1 reference
John Radford
1 reference
4 April 2008
1 reference
1 reference
111
1 reference
12
1 reference
5486-5495
1 reference
Identifiers
1 reference
1 reference